Eyenovia Inc (EYEN)
0.71
+0.13 (22.41%)
Upcoming Events
Latest Headlines
Eyenovia Inc (EYEN) Provides Clinical and Scientific Update on Mydcombi and Clobetasol
April 25, 2024 7:01 AM - StreetInsider
Eyenovia Provides Clinical and Scientific Update on FDA-Approved Products Mydcombi™ and Clobetasol Propionate Ophthalmic Suspension
April 25, 2024 7:00 AM - StreetInsider
Form PRE 14A EYENOVIA, INC. For: Jun 12
April 23, 2024 5:13 PM - SEC Filing
Form 8-K EYENOVIA, INC. For: Apr 09
April 10, 2024 8:01 AM - SEC Filing
Form 424B5 EYENOVIA, INC.
April 10, 2024 6:02 AM - SEC Filing
Form 8-K EYENOVIA, INC. For: Apr 08
April 9, 2024 8:45 AM - SEC Filing
Form 8-K EYENOVIA, INC. For: Apr 08
April 8, 2024 5:24 PM - SEC Filing
Eyenovia Inc (EYEN) Announces Updated Strategy and Corporate Priorities
April 8, 2024 7:02 AM - StreetInsider
Eyenovia Announces Updated Strategy and Corporate Priorities to Focus on Shareholder Value Generation and Immediate Commercial Opportunities
April 8, 2024 7:00 AM - StreetInsider
Eyenovia to Feature its Suite of Commercial Products and the Optejet Dispenser at Upcoming National Eyecare Meetings
April 3, 2024 7:00 AM - StreetInsider
Form 4 EYENOVIA, INC. For: Mar 28 Filed by: Grant Stuart M.
March 28, 2024 3:50 PM - SEC Filing
Form 4 EYENOVIA, INC. For: Mar 19 Filed by: Grant Stuart M.
March 20, 2024 5:44 PM - SEC Filing
Form 8-K EYENOVIA, INC. For: Mar 19
March 19, 2024 8:40 AM - SEC Filing
Eyenovia Inc (EYEN) Misses Q4 EPS by 1c
March 18, 2024 4:18 PM - StreetInsider
Form 10-K EYENOVIA, INC. For: Dec 31
March 18, 2024 4:18 PM - SEC Filing
Eyenovia Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update
March 18, 2024 4:05 PM - StreetInsider
Eyenovia Inc (EYEN) and NovaBay (NBAY) to Co-Promote Prescription Ophthalmic Products in the US
March 13, 2024 7:04 AM - StreetInsider
NovaBay Pharmaceuticals and Eyenovia to Co-Promote Prescription Ophthalmic Products to U.S. Eyecare Professionals
March 13, 2024 7:00 AM - StreetInsider
Form 4 EYENOVIA, INC. For: Mar 08 Filed by: Grant Stuart M.
March 11, 2024 8:11 AM - SEC Filing
Eyenovia to Report Fourth Quarter 2023 Results and Provide Business Update on Monday, March 18th
March 11, 2024 7:00 AM - StreetInsider
Eyenovia Congratulates Formosa Pharmaceuticals on FDA Approval of Clobetasol Propionate Ophthalmic Suspension 0.05% for the Treatment of Post-operative Inflammation and Pain Following Ocular Surgery
March 5, 2024 8:00 AM - StreetInsider
Formosa Pharmaceuticals and AimMax Therapeutics Receive FDA Approval for Clobetasol Propionate Ophthalmic Suspension 0.05%, for the Treatment of Post-Operative Inflammation and Pain Following Ocular S
March 4, 2024 5:55 PM - PR NewsWire
Form 4 EYENOVIA, INC. For: Feb 12 Filed by: GANDOLFO JOHN P
February 14, 2024 4:16 PM - SEC Filing
Form 4 EYENOVIA, INC. For: Feb 12 Filed by: Rowe Michael M
February 14, 2024 4:14 PM - SEC Filing
Form 4 EYENOVIA, INC. For: Feb 12 Filed by: Kern Bren
February 14, 2024 4:12 PM - SEC Filing
Form SC 13G EYENOVIA, INC. Filed by: ARMISTICE CAPITAL, LLC
February 14, 2024 3:37 PM - SEC Filing
Eyenovia Inc (EYEN) Announces FDA Approval of Redwood City as Commercial Manufacturing Facility
February 13, 2024 7:00 AM - StreetInsider
Eyenovia Announces FDA Approval of Redwood City as Commercial Manufacturing Facility
February 13, 2024 7:00 AM - StreetInsider
Form 8-K/A EYENOVIA, INC. For: Jan 25
January 31, 2024 8:14 AM - SEC Filing
Full Article List
